PDF herunterladen
Perspectives in Vascular Surgery 2001; 14(1): 0129-0162
DOI: 10.1055/s-2001-13853
Copyright © 2001 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel. +1(212)584-4662.

Mock Trial: Who Is Responsible for Access to Emerging Technology, Specifically Endoluminal AAA Surgery?

Hugh E. Scully, Wayne R. Tanner, Frank J. Veith, Scott Rowand, Philip C. Hébert, Hon. Madame Justice M. MacDonald
  • Division of Cardiovascular Surgery, Toronto General Hospital, Toronto, Ontario (HES); Don Valley Medical Center, Toronto East General Hospital, Toronto, Ontario (WRT); Department of Surgery, Division of Vascular Surgery, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY (FJV); Hamilton Health Sciences Corporation, McMaster University Health Center, Hamilton, Ontario (SR); Sunnybrook Health Sciences Center, Toronto, Ontario, Canada (PCH); Superior Court of Justice, Toronto, Ontario (JMM)
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
31. Dezember 2001 (online)

 als PDF herunterladen Lizenzen und Reprints

ABSTRACT

-The case is a 75-year-old male patient with a large abdominal aortic aneurysm (AAA). He has a very high operative risk because of associated cardiac disease, and is turned down for elective repair. One month later, the aneurysm ruptures and the patient dies. The family reads in the newspaper that similar AAAs can be repaired using minimally invasive techniques, that are only available in Canada on a compassionate basis because of the high cost. The family decides to initiate a civil suit. Presentations are heard from the defense (vascular surgeon), prosecution expert witness, hospital administration, and an ethicist. At the conclusion, a legal judgment will be provided by a justice of the Supreme Court of Ontario. Who is responsible?

KEYWORD

Endovascular - aneurysm - stent